I rate AbbVie stock as a Strong Buy, based on its FDA approval of Rinvoq. Read the latest analysis on the stock here.

Susan Perlbachs, chief creative officer of Eversana Intouch, discusses how marketers are navigating a new world order of scrutiny.

The Food and Drug Administration (FDA) has approved updated indications for Rinvoq® (upadacitinib) in the treatment of adults with moderately to severely active ulcerative colitis (UC) or Crohn ...

The cold and flu brand generated an impressions SOV of 4.71% and 2.9 billion impressions, primarily through CBS and its show GMA 3: What You Need to Know. The Proctor and Gamble brand invested $10.3 ...

Return on investment has been stronger than expected as the B2B firm turns to connected TV, said a company marketing director ...

The company was one of many to get letters last month from the US Food and Drug Administration calling out what the agency believes are misleading commercials.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Starting today, the U.S. imposed 100% tariffs on imports ...

Joins global brands Goldman Sachs, KITON, FLOKI, Ford Motors, and IMG Academy in going viral across NTTS’s YouTube and social media platforms NEW YORK, NY / ACCESS Newswire / September 25, 2025 / New ...

(The Center Square) – The results of a May executive order aiming to reform drug pricing are beginning to materialize, per an administration announcement Tuesday. Major pharmaceutical manufacturer ...